Skip to content
10-Q/A

Quarterly Report

HASCO Medical, Inc.

0001161697-14-000105

← back to feed
Filed
Mar 13, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Jul 31, 2013 988.31M sh
Shares Diluted restated Q2 2013 · Jun 30, 2013 988.28M sh
Shares Diluted Q2 2013 · Jun 30, 2012 977.11M sh
Capex Q2 2013 · Jun 30, 2013 $125.01K
Capex restated Q2 2013 · Jun 30, 2012 $211.38K
Operating Cash Flow restated Q2 2013 · Jun 30, 2013 $789.42K
Operating Cash Flow restated Q2 2013 · Jun 30, 2012 −$346.16K
Long Term Debt Q2 2013 · Jun 30, 2013 $6.22M
Long Term Debt Q2 2013 · Dec 31, 2012 $6.39M
Cash And Equivalents Q2 2013 · Jun 30, 2013 $1.07M
Cash And Equivalents Q2 2013 · Dec 31, 2012 $850.39K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $1.25M
Cash And Equivalents Q2 2013 · Dec 31, 2011 $212.46K
Stockholders Equity restated Q2 2013 · Jun 30, 2013 $1.75M
Stockholders Equity restated Q2 2013 · Dec 31, 2012 $1.69M
Stockholders Equity restated Q2 2013 · Jun 30, 2012 $1.8M
Current Liabilities restated Q2 2013 · Jun 30, 2013 $18.93M
Current Liabilities restated Q2 2013 · Dec 31, 2012 $18.45M
Current Liabilities restated Q2 2013 · Jun 30, 2012 $20.23M
Total Liabilities restated Q2 2013 · Jun 30, 2013 $26.03M
Total Liabilities restated Q2 2013 · Dec 31, 2012 $25.37M
Total Liabilities restated Q2 2013 · Jun 30, 2012 $27.72M
Current Assets restated Q2 2013 · Jun 30, 2013 $19.12M
Current Assets restated Q2 2013 · Dec 31, 2012 $18.63M
Current Assets restated Q2 2013 · Jun 30, 2012 $20.28M
Total Assets restated Q2 2013 · Jun 30, 2013 $27.78M
Total Assets restated Q2 2013 · Dec 31, 2012 $27.07M
Total Assets restated Q2 2013 · Jun 30, 2012 $29.51M
Sga Expense restated Q2 2013 · Jun 30, 2013 $2.57M
Sga Expense restated Q2 2013 · Jun 30, 2013 $5.06M
Sga Expense restated Q2 2013 · Jun 30, 2012 $3.49M
Sga Expense restated Q2 2013 · Jun 30, 2012 $5.26M
Net Income restated Q2 2013 · Jun 30, 2013 $250.68K
Net Income restated Q2 2013 · Jun 30, 2013 $51.99K
Net Income restated Q2 2013 · Jun 30, 2012 $233.92K
Net Income restated Q2 2013 · Jun 30, 2012 $292.89K
Operating Income restated Q2 2013 · Jun 30, 2013 $325.08K
Operating Income restated Q2 2013 · Jun 30, 2013 $25.19K
Operating Income restated Q2 2013 · Jun 30, 2012 $435.42K
Operating Income restated Q2 2013 · Jun 30, 2012 $706.32K
Gross Profit restated Q2 2013 · Jun 30, 2013 $4.06M
Gross Profit restated Q2 2013 · Jun 30, 2013 $7.24M
Gross Profit restated Q2 2013 · Jun 30, 2012 $4.3M
Gross Profit restated Q2 2013 · Jun 30, 2012 $6.48M
Cost Of Revenue restated Q2 2013 · Jun 30, 2013 $14.65M
Cost Of Revenue restated Q2 2013 · Jun 30, 2013 $26.42M
Cost Of Revenue restated Q2 2013 · Jun 30, 2012 $15.18M
Cost Of Revenue restated Q2 2013 · Jun 30, 2012 $21.54M
Revenue restated Q2 2013 · Jun 30, 2013 $18.71M
Revenue Q2 2013 · Jun 30, 2013 $33.67M
Revenue restated Q2 2013 · Jun 30, 2012 $19.48M
Revenue restated Q2 2013 · Jun 30, 2012 $28.02M